CORDIS · 726400 · H2020
TEA Theory and Empirics of Asymmetry
Coordinator: BILKENT UNIVERSITESI VAKIF (TR)
Why is there a Volcker disinflation but no Bernanke re-inflation? It is not only because of the zero lower bound as a nascent literature is suggesting that monetary policy is more potent in a contractionary stance than in an expansionary stance away from the ZLB as well. But why? Why is it that central banks cut interest rates much faster than they raise them? Why does it seem like financial markets give much different responses to seemingly similar macroeconomic news at different times? Are these all related? This research project is about asymmetries in macroeconomics and finance. I will be…
About Horizon 2020 (2014–2020)
Horizon 2020 was the EU's flagship research and innovation programme for 2014–2020, with a budget of around €77 billion. It bundled FP7's strands with the EIT and the Competitiveness and Innovation Programme, introduced a stronger societal-challenge orientation, and pushed the funding logic toward closer-to-market innovation. New calls closed in 2020 but funded projects continued through 2024.
EU contribution: €1.3M awarded to the consortium. The project runs over approximately 5.5 years from 2017-03-01 to 2022-08-31.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu → Grant DOI ↗More from TR
see all →- CoCirculation3 — CO-FUNDED Brain Circulation 3101179377 · HORIZON · €9.6M
- TEAM-NANO — Teaming for Capacity Development and Synergies in Micro-nanofabrication and Flexible Electronics for Widespread Impact101136388 · HORIZON · €9.0M
- SHEREC — SAFE, HEALTHY AND ENVIRONMENTAL SHIP RECYCLING101136056 · HORIZON · €8.0M
- CoCirculation2 — CO-FUNDED Brain Circulation Scheme 2801509 · H2020 · €6.2M
- DIAMETER — Demonstration of a sustainable circular-by-design manufacturing system based on additive manufacturing101177422 · HORIZON · €6.0M
- HSMonitor — Pre-commercial Procurement of innovative ICT-enabled monitoring to improve health status and optimise hypertension care856698 · H2020 · €5.9M
Other H2020 projects
see all →- EUROfusion — Implementation of activities described in the Roadmap to Fusion during Horizon 2020 through a Joint programme of the members of the EUROfusion consortium633053 · DE · €678.8M
- H2020 — COST at a turning point: A unique framework for pan-European ST cooperation as clear demonstration of European values681463 · BE · €178.2M
- HBP SGA3 — Human Brain Project Specific Grant Agreement 3945539 · BE · €150.0M
- COVID-19 VACCINES — PROPOSAL FOR FUNDING RESEARCH DEVELOPMENT AND MANUFACTURING OF VACCINE AGAINST COVID-19101018100 · NO · €100.0M
- UNITE4TB — ACADEMIA AND INDUSTRY UNITED INNOVATION AND TREATMENT FOR TUBERCULOSIS101007873 · NL · €92.5M
- ERA4TB — EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS853989 · ES · €89.8M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Horizon 2020 (2014–2020) programme, under the ERC-COG funding scheme.
- What is the EU contribution?
- The European Commission contributes €1.3M toward a total project budget of €1.3M.
- Which EU programme funds it?
- The project is funded under Horizon 2020 (2014–2020), call ERC-2016-COG.
- Who coordinates the project?
- The project is coordinated by BILKENT UNIVERSITESI VAKIF (TR).
- What is the project timeline?
- The project runs from 2017-03-01 to 2022-08-31 — approximately 5.5 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 726400.